Product NewsLife Sciences
Challenging host cell protein assays for improved risk mitigation
4 Nov 2022
Watch this video presented by Andrew Hamilton, Cytiva, titled: Challenging host cell protein assays for improved risk mitigation.
About the company

Cytiva
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex and Xuri. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients. Visit cytiva.com for more.







